Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

HIV Preexposure Prophylaxis (PrEP): Exploring the Current and Emerging Landscape | PTCE Pharmacy Connect Jul 29, 2022

Show notes

Educational Objectives · Discuss currently available options for pre-exposure prophylaxis (PrEP) in the prevention of HIV. · Describe the role of pharmacists in improving PrEP uptake in the United States. Faculty: Drew W. Cates, PharmD, AAHIVP, Educational Manager SynerGrx Chamblee, Georgia Faculty, has the following financial relationships with commercial interests to disclose: Speaker's Bureau: Gilead Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.07 CEU) under the ACPE universal activity number 0290-0000-22-338-H02-P. The activity is available for CE credit through July 29, 2023. This activity is supported by an educational grant from ViiV. Learn more about your ad choices. Visit megaphone.fm/adchoices

Examining the Treatment Landscape of Metastatic NSCLC Expressing the Targetable Mutations RET, MET, and KRAS | PTCE Pharmacy Connect Jul 29, 2022

Show notes

Educational Objectives • Review the targetable mutations RET, MET, and KRAS, including associated agents for the treatment of metastatic non-small cell lung cancer (NSCLC) • Discuss the ways a pharmacist may improve adherence, toxicity management, and outcomes for patients with metastatic NSCLC expressing RET, MET, and KRAS mutations Josiah D. Land, PharmD, BCOP Clinical Pharmacy Specialist – Thoracic Medical Oncology Department of Pharmacy Memorial Sloan Kettering Cancer Center New York, New York Josiah D. Land, PharmD, BCOP, has the following financial relationship with a commercial interest to disclose: Consultant (advisory board): Bristol Myers Squibb Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number0290-0000-22-388-H01-P. The activity is available for CE credit through July 29, 2023. This activity is supported by educational funding provided by Amgen. Learn more about your ad choices. Visit megaphone.fm/adchoices

”Sex Matters” with Dr Alyson McGregor | Sex PharmD Jul 29, 2022

Show notes

This episode interviews Dr Alyson McGregor, MD Professor of Emergency Medicine and Associate Dean of Clinical Faculty Affairs and Development at University of South Carolina School of Medicine Greenville. Dr McGregor is a sex and gender expert, educator and advocate. Dr McGregor discusses her book, Sex Matters: How Male-Centric Medicine Endangers Women's Health and What We Can Do About It. https://www.alysonmcgregormd.com/ @amcgregormd Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuing the Conversation: Optimizing Frontline Immunotherapy Outcomes in NSCLC and Managed Care Considerations | PTCE Pharmacy Connect Jul 28, 2022

Show notes

Educational Objectives · Review the efficacy and safety of emerging frontline immune checkpoint inhibitor (ICI) used as monotherapy and in combination regimens · Indicate the impact of ICIs and programmed death-ligand 1 testing on cost-effectiveness and patient reported outcomes related with frontline use of ICIs in advanced NSCLC Faculty: Paul Forsberg, PharmD, MHA, BCOP Director of Pharmacy Minnesota Oncology St. Paul, Minnesota Latha Radhakrishnan, PharmD, BCOP Clinical Oncology Pharmacist The University of Illinois Hospital and Health Sciences System Clinical Assistant Professor University of Illinois at Chicago College of Pharmacy Chicago, Illinois Paul Forsberg, PharmD, MHA, BCOP, has the following relevant financial relationships with commercial interests to disclose: Consultant: Epizyme Speakers Bureau: AstraZeneca Latha Radhakrishnan, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Consultant: Taiho, Novartis, Exelixis Speakers Bureau: BMS, AstraZeneca, Taiho, Exelixis Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta. Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-22-363-H01-P. The activity is available for CE credit through July 29, 2023. This activity is supported by independent medical education grants from Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Inc., and Sanofi Genzyme. https://www.pharmacytimes.org/courses/continuing-the-conversation-optimizing-frontline-immunotherapy-outcomes-in-nsclc-and-managed-care-considerations Learn more about your ad choices. Visit megaphone.fm/adchoices

4 Can’t Miss Trends about Digital Engagement with Ritesh Patel | DarshanTalks Jul 28, 2022

Show notes

4 Can't Miss Trends about Digital Engagement! Coming up on Friday's livestream of the DarshanTalks Podcast with host Darshan Kulkarni and guest Ritesh Patel, originally streamed on July 15th, 2022. Learn more about your ad choices. Visit megaphone.fm/adchoices

Implementing G6 into Pharmacy Practice | Real Time Real Talk Jul 27, 2022

Show notes

Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to Dexcom G6 User Guide. For product-related questions, please refer to instructions for use. For complete safety information, go to dexcom.com/safety-information Smart devices are sold separately. For a list of compatible smart device visit Dexcom.com/compatibility Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products. The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G6 System User Guide Safety Information https://www.dexcom.com/safety-information Dexcom Follow app: The Dexcom G6 App allows you to share your glucose data with up to 10 people. By downloading the Dexcom Follow App, followers can view your glucose data directly from their smart device† whether they live down the street or across the country*. Connectivity – basics (https://provider.dexcom.com/dexcom-cgm/collaborators) About Dexcom https://www.dexcom.com/about-Dexcom Beacon Health System Resources Dexcom Patient Training and Resources Dexcom Prescribing Information Brief Safety Statement Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. The web-based Dexcom CLARITY software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional. Dexcom, Dexcom Follow, Dexcom CLARITY, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. References: 1. William H. Polonsky, Emily C. Soriano, and Addie L. Fortmann. Diabetes Technology & Therapeutics. Ahead of print http://doi.org/10.1089/dia.2021.0526 2. Shah VN, et al. Diabetes Technology & Therapeutics. 2018;20(S1):A-27 DOI: 10.1089/dia.2018.0143 3. Kaushik S, et al. Diabetes. 2020 Jun;69(Supplement 1) https://doi.org/10.2337/db20-79-LB Learn more about your ad choices. Visit megaphone.fm/adchoices

The Good, The Bad, & The Ignorant: The Twisted World of PCMA Politics | PUTTcast Jul 26, 2022

Show notes

Solid PR practices call for changing the conversation to one's advantage, but PCMA's recent OpEds based on a paid-for white paper are more than suspect. Listen in as lobbyist & managing partner of Public Policy Partners Meghaen Della'Artino, and General Counsel for American Pharmacies Miguel Rodriguez, speak with PUTTcast host Monique Whitney about strategy, the current political arena, and how the power of grassroots and a constituent's voice can overcome the most well-funded PBM politics. Learn more about your ad choices. Visit megaphone.fm/adchoices

Diagnostic Testing in Community Pharmacies | Pharmacy Podcast Nation Jul 26, 2022

Show notes

Babson Diagnostics and Pharmacy Podcast Network Announce Partnership That Will Take Listeners Inside Largest Retail Pharmacy Trade Show Babson to host popular podcast from its booth at the Total Store Expo July 26, 2022 Austin, Texas– Babson Diagnostics, a science-first, health care technology company, today announced a media partnership with the Pharmacy Podcast Network in connection with the 2022 National Association of Chain Drug Stores’ Total Store Expo, the largest gathering of retailers and suppliers in the health and wellness industry. As part of the partnership, the Pharmacy Podcast Network, the most popular and downloaded podcast about the pharmacy industry, will be integrated into Babson Diagnostics’ booth at the Total Store Expo. Todd Eury, founder and chief executive officer of the media company, will host podcasts from the booth featuring industry leaders attending the trade show. In addition, Babson will sponsor two podcasts that will be broadcast prior to the expo, which takes place Aug. 27 through Aug. 29 in Boston. The first of those shows, “Diagnostic Testing in Community Pharmacies” went live today. “Babson is excited to be collaborating with one of the leading media outlets aimed at community pharmacists, who are the face of neighborhood healthcare, said David Stein, CEO of Babson Diagnostics. “Babson is working with pharmacies to offer medically accurate blood testing that is easier, more convenient and less invasive than traditional methods.” Launched in 2009, the Pharmacy Podcast Network reaches more than 80,000 listeners per month with audio content focused on the critical role pharmacists play in the healthcare industry. “I look forward to bringing exciting new content to my audience through this partnership with Babson Diagnostics,” Eury said. “The Total Store Expo is a one-of-a-kind opportunity to bring insights to pharmacists about new and innovative products and services in health and wellness, such as Babson’s blood-testing ecosystem.” Please visit the Babson at booth #359 at the Total Store Expo to see Eury’s interviews, view the blood testing ecosystem, experience the collection technology, meet the team and more. Sign up at www.babsondx.com/nacds About Babson Diagnostics Babson Diagnostics is a science-first healthcare technology company bringing convenient, medically accurate diagnostic blood testing to the local pharmacy. We are the first and only company to do broad blood panels from a capillary microsample, collected from a finger, at a retail setting. Our core technology was incubated at Siemens Healthineers in 2015, and we became Babson Diagnostics in 2017. We have exclusive partnerships with Siemens Healthineers and BD (Becton, Dickinson and Company), two global leaders in healthcare innovation and medical technology. Together we are reimagining the entire blood testing process, helping people get the care they need, when they need it. Babson, based in Austin, Texas, is named in honor of Art Babson, whose legacy of scientific innovation and excellence is the foundation on which the company is built. For more information visit www.babsondx.com and find us on Facebook (@babsondx), Twitter (@babsondx) and LinkedIn (@babsondx). About Pharmacy Podcast Network Pharmacy Podcast Nation is the flagship show hosting all of the Pharmacy Podcast Network 1400+ episodes. With more than 30 different podcast programs and some 40 different co-hosts helping to develop audio content about the pharmacy sector, its reach includes communities, hospitals, senior-care residences, military and public health settings that meet the information needs of 300,000 pharmacists with more than 100,000 monthly listeners. PPN also delivers a unique publication called Rx Influencer to all healthcare professionals with a specific focus on pharmacy. For more information visit: https://pharmacypodcast.com/ Contacts: Babson Joe Foster Babson Diagnostics babsonDX@finnpartners.com 323-572-5361 Learn more about your ad choices. Visit megaphone.fm/adchoices

Facing the Nursing Shortage Head-on | The Future of Pharmacy Podcast Jul 23, 2022

Show notes

COVID-19 has reminded us of the importance of nurses in our lives and why we must invest in them. Healthcare is one of the hardest-hit areas of the Great Resignation, with stress and burnout leading to nurses leaving the profession in high numbers. Learn from prominent healthcare experts how to limit the impact of nursing shortages by leveraging intelligent infrastructure, automation, and data intelligence. Learn more about your ad choices. Visit megaphone.fm/adchoices

Caring for Patients With Multiple Myeloma Through Pharmacist-Directed Supportive Care and Toxicity Management Strategies | PTCE Pharmacy Connect Jul 22, 2022

Show notes

Introduction of faculty and disclosures: Dr. Kathryn Maples is a clinical pharmacy specialist in multiple myeloma at the Winship Cancer Institute with Emory Healthcare in Atlanta, Georgia. Dr. Maples has the following relevant financial relationships with commercial interests to disclose: consultant for GlaxoSmithKline, Janssen, Karyopharm, and Sanofi. Accreditation and support statement: PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC https://www.pharmacytimes.org/courses/multiple-myeloma-pharmacists-as-therapy-experts Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts